Cover Image

Reasons for Healthcare Use Before Onset of Multiple Sclerosis: A Nationwide Matched Cohort Study in Sweden

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Ali Manouchehrinia, Yinshan Zhao, Feng Zhu, Kyla McKay, Colleen Maxwell, Ruth Ann Marrie, Helen Tremlett
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	European Journal of Neurology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Phenotyping Healthcare Use 2–3 Decades Before the First Multiple Sclerosis Demyelinating Event
by: Helen Tremlett, et al.
Published: (2025)

Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis
by: Ali Manouchehrinia, et al.
Published: (2025)

Shared Genetic Effects and Antagonistic Pleiotropy Between Multiple Sclerosis and Common Cancers
by: Asli Buyukkurt, et al.
Published: (2026)

Epstein–Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein‐Antibody‐Associated Disease
by: Giulia Fadda, et al.
Published: (2024)

De‐Escalation of Disease‐Modifying Therapy in Multiple Sclerosis—A Danish Nationwide Cohort Study
by: Frederik Elberling, et al.
Published: (2025)

Neurofilament Light Chain Concentration in the Prediction of Treatment Response in Multiple Sclerosis
by: Nahid Moradi, et al.
Published: (2026)

Clusters of Comorbidities in Multiple Sclerosis and Their Influence on Healthcare Resource Usage
by: Simón Cárdenas‐Robledo, et al.
Published: (2025)

Pre‐Diagnostic Features of Multiple Sclerosis in a Diverse UK Cohort: A Nested Case–Control Study
by: Pooja Tank, et al.
Published: (2025)

Wine Glass Sign in Bulbar Onset Amyotrophic Lateral Sclerosis
by: Prashant Bhatele, et al.
Published: (2024)

Letter on Wine Glass Sign in Bulbar‐Onset Amyotrophic Lateral Sclerosis
by: Yu Zhu, et al.
Published: (2025)

Differences in Income Growth Between People With Multiple Sclerosis and Controls: A Norwegian Cohort Study
by: Anne Høgset, et al.
Published: (2026)

Longitudinal Brain Atrophy Patterns in Early MOG ‐Antibody Associated Disease and Relapsing Multiple Sclerosis
by: Theodoros Ladopoulos, et al.
Published: (2025)

Reply to “Methodological Considerations in the Nationwide Cohort Study of Cerebral Amyloid Angiopathy”
by: Samuel S. Bruce, et al.
Published: (2025)

Stratifying Multiple Sclerosis Susceptibility Risk: The Role of HLA‐E*01 and Infectious Mononucleosis in a Population Cohort
by: Andrea Nova, et al.
Published: (2025)

Distinct Prescription Patterns Emerge Years Before ALS Diagnosis: A Nationwide Registry‐Based Study
by: Magne Haugland Solheim, et al.
Published: (2026)

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss
by: Simon Englund, et al.
Published: (2025)

Erythrocyte Fragility in Progressive Multiple Sclerosis
by: Carmen Jacob, et al.
Published: (2026)

New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond
by: Gary Birnbaum
Published: (2025)

Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
by: Massimiliano Calabrese, et al.
Published: (2024)

Social Cognition in Multiple Sclerosis: A Multidomain Investigation
by: Dalya Eda Akbalık, et al.
Published: (2026)

The Epidemiology of Primary Lateral Sclerosis: Results from a Population‐Based Cohort
by: Rosario Vasta, et al.
Published: (2025)

Fighting Amyotrophic Lateral Sclerosis by Protecting the Liver? A Prospective Cohort Study
by: Luyi Zhu, et al.
Published: (2024)

Serum Neurofilament Light Is Associated With Future Disease Activity in Clinically Isolated Syndrome and Early Multiple Sclerosis Only After Non‐Optic Neuritis Onset
by: Philipp Klyscz, et al.
Published: (2025)

Towards a Unified Set of Diagnostic Criteria for Multiple Sclerosis
by: Wallace J. Brownlee, et al.
Published: (2024)

Obesity and Multiple Sclerosis Severity: A Mendelian Randomization Study
by: Fatema Alzamanan, et al.
Published: (2024)

Reply to “New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond”
by: Joseph J. Sabatino, et al.
Published: (2025)

Hospital‐Treated Infections and Risk of Disability Worsening in Multiple Sclerosis
by: Yihan Hu, et al.
Published: (2024)

Epstein–Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA ‐ DRB1 *1501 Risk Variant Share Common Epigenetic Pathways Leading to Multiple Sclerosis Onset
by: Steve Simpson‐Yap, et al.
Published: (2025)

Angiographic Characteristics and Progression in A Comprehensive Nationwide European MOYAMOYA Cohort
by: Peter Birkeland, et al.
Published: (2025)

Network Localization of Fatigue in Multiple Sclerosis
by: Olli Likitalo, et al.
Published: (2025)

Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis
by: Monica Margoni, et al.
Published: (2024)

Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients
by: Matthew R. Brier, et al.
Published: (2024)

Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study
by: Dimitrios Papadopoulos, et al.
Published: (2025)

Suicide Risk and Associated Factors in Parkinson Disease: A Nationwide Cohort Study
by: Seo Yeon Yoon, et al.
Published: (2025)

High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort Study
by: Richard Nicholas, et al.
Published: (2024)

Distortion in the Communication of Nonsignificant Primary Outcomes: The Spin Strategy in Multiple Sclerosis Trials
by: Marta Mascareñas‐García, et al.
Published: (2026)

Understanding Routine Treatment and Resource Availability for Fatigue in Multiple Sclerosis in the United Kingdom
by: Federica Picariello, et al.
Published: (2026)

Neuropathological Evidence of Reduced Amyloid Beta and Neurofibrillary Tangles in Multiple Sclerosis Cortex
by: J. Pansieri, et al.
Published: (2025)

A Patient‐Derived Antibody Ameliorates Disease Severity in a Relapsing Remitting Murine Model of Multiple Sclerosis
by: Chad Smith, et al.
Published: (2026)

Frailty Exacerbates Disability in Progressive Multiple Sclerosis
by: Taylor R. Wicks, et al.
Published: (2025)